Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
about
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytesMolecular diagnosis of mast cell disorders: a paper from the 2005 William Beaumont Hospital Symposium on Molecular PathologyAdvances in the understanding and clinical management of mastocytosis and clonal mast cell activation syndromesValidation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.Systemic mastocytosis with KIT V560G mutation presenting as recurrent episodes of vascular collapse: response to disodium cromoglycate and disease outcomeClinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposalAdvances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future.Diagnosis and treatment of mast cell disorders: practical recommendations.Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcomeImmunophenotyping of acute leukemias and myelodysplastic syndromes.Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosisInternational Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.Adult mastocytosis: a review of the Santo António Hospital 's experience and an evaluation of World Health Organization criteria for the diagnosis of systemic disease.FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816HFunctions and uses of immunohistochemical stains in cutaneous infiltrates of hematopoietic origin: a review for the practicing dermatologist.Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.Current state of biology and diagnosis of clonal mast cell diseases in adults.Mast Cell Leukaemia: c-KIT Mutations Are Not Always Positive.Immunology and clinical manifestations of non-clonal mast cell activation syndromeAnaphylaxis as a clinical manifestation of clonal mast cell disorders.Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease.FLOCK cluster analysis of mast cell event clustering by high-sensitivity flow cytometry predicts systemic mastocytosis.Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V.Absence of circulating mast cell precursors in paediatric mastocytosis: could it reflect a different pathophysiology between adults and children with mastocytosis?Immunohistochemical assessment of CD25 is equally sensitive and diagnostic in mastocytosis compared to flow cytometry.Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.Evaluation of the WHO criteria for the classification of patients with mastocytosis.Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis.First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.High-sensitivity flow cytometric analysis of mast cell clustering in systemic mastocytosis: a quantitative and statistical analysis.
P2860
Q24604581-3D197896-9E49-450B-B040-4192DB91B586Q24685914-4C9433E5-D3F6-4E96-BEE3-445DC6204A7DQ28078468-EAC15B63-B76F-4ED5-8799-71025FAA846DQ33160609-09E2595E-7B61-4AE2-9EA3-74876B4887D9Q33168552-05E206AD-3C1E-4D35-9EA8-8B718ED471CFQ33431360-9FD51D08-BE03-4A34-B36E-3EB49769ECA3Q34137971-D0391033-CD33-4D3F-8DB6-FE7E94BFAE0AQ34552564-432594BA-802B-4D36-A1DD-1E63A267CC7BQ35021196-4297B974-28DF-46EA-A2DE-FE8F31013801Q35025246-795825F8-3776-4DE2-939F-7B6B63BA1234Q35679885-02CF06A0-1E65-4E33-8826-D2EFABAD56A9Q35757696-46A7FDF1-FBD1-4962-BDD6-7B9B661DDE16Q35951578-F68D1E64-8431-4B7F-A0B2-9012145F5DC5Q36730397-A5D763D5-9D21-4A08-A73A-D8FCB273B3EFQ36977300-5C1D0B8E-C08F-4EA1-B7B1-A649172746C5Q37609846-4C058F97-3666-439F-AD28-2BBD2544C30BQ37611613-AC24560E-86D5-4A05-8639-11B8D2B3A638Q37863265-3A6ED9D1-E1F4-4DEF-99D9-75EC4B04889BQ37873485-2D09A980-B349-462F-906D-BBA2689290F6Q38007005-8C1531A5-F5B3-4C01-AE54-9A02825AB2BAQ38045311-0DE936A2-F5F1-44BE-982F-19CB9213836FQ38065108-24FCFB91-1F48-4377-9973-A25A16B28B7AQ38221739-89D73A11-A197-4AAB-B74F-8A7AEAFCDFFDQ38543373-8ADAF31B-E37F-41EB-B317-240565ECDB3FQ38582624-FF98F75F-E4CC-4FA8-A281-735E5D155BD5Q40408925-E5B988CE-89E6-4471-883B-A5139A8FC742Q40976858-E44B9FAD-B74A-4222-8A0B-AD2071B380FAQ41130396-00AB58CB-FA98-4805-8FA6-AA4B68384E26Q43696284-D467F3F7-F72E-477D-B73E-99B0926D4AEEQ44198970-D4A03EA9-C3A7-457B-B2D2-B7C20C2AD180Q45730180-8C00CB06-2963-4E18-8C0A-2FEA042A909BQ47584723-A6CF2334-59EA-4D0D-A0EC-0CE6B2BCB72BQ50484927-7AAE1B09-5B2B-42D0-8E0B-0261044B8323Q51505022-67E5E4EA-7057-4019-A3FC-32E1FFD56CB4Q51571187-479301BE-0233-4D18-B481-1980830BABE2Q52719340-2420DB92-24B4-4A1C-B8CB-7AE1699212D7Q53056362-1AFDD66A-653D-4C38-95A3-3E44EA5E9005Q53093872-7C9E9E89-0741-4423-A688-1A18B881FD9CQ53315532-11A61AB3-E064-4724-8356-EE5DFCB89656Q54317513-F393C44B-0B72-44FB-A0DD-24176F9235DF
P2860
Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it. Proposals of the Spanish Network on Mastocytosis (REMA).
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Immunophenotypic analysis of m ...... etwork on Mastocytosis (REMA).
@en
Immunophenotypic analysis of m ...... panish Network on Mastocytosis
@nl
type
label
Immunophenotypic analysis of m ...... etwork on Mastocytosis (REMA).
@en
Immunophenotypic analysis of m ...... panish Network on Mastocytosis
@nl
prefLabel
Immunophenotypic analysis of m ...... etwork on Mastocytosis (REMA).
@en
Immunophenotypic analysis of m ...... panish Network on Mastocytosis
@nl
P2093
P356
P1476
Immunophenotypic analysis of m ...... etwork on Mastocytosis (REMA).
@en
P2093
Alberto Orfao
Antonio López
Aranzazu Prados
Beatriz Diaz-Agustin
Julia Almeida
Luis Escribano
Miguel Angulo
Rosa Núñez López
Sonia Herrero
Spanish Network on Mastocytosis (REMA)
P2860
P356
10.1002/CYTO.B.10072
P577
2004-03-01T00:00:00Z